机构:[1]Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China[2]School of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China[3]School of Traditional Chinese Medicine, the Southern Medical University, Guangzhou, Guangdong, China[4]Department of Rheumatology, the First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China深圳市中医院深圳医学信息中心
National Natural Science Foundation of China (no 81573930), Guangdong Natural
Science Foundation (no 2014A030313403) and Guangdong Province
High Level University Construction Foundation (no
AFD018171Z11056).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|3 区医学
小类|3 区免疫学3 区药学
最新[2025]版:
大类|2 区医学
小类|2 区药学3 区免疫学
第一作者:
第一作者机构:[1]Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
共同第一作者:
通讯作者:
通讯机构:[3]School of Traditional Chinese Medicine, the Southern Medical University, Guangzhou, Guangdong, China[4]Department of Rheumatology, the First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China[*1]School of Traditional Chinese Medicine, the Southern Medical University, No. 1023-1063 Shatai Road, Guangzhou, Guangdong 510515, China[*2]Department of Rheumatology, the First Affiliated Hospital, Guangzhou University of Chinese Medicine, No. 16 Jichang Road, Guangzhou, Guangdong 510405, China.
推荐引用方式(GB/T 7714):
Pan Dongmei,Li Nan,Liu Yanyan,et al.Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway.[J].International immunopharmacology.2018,55:174-182.doi:10.1016/j.intimp.2017.12.011.
APA:
Pan Dongmei,Li Nan,Liu Yanyan,Xu Qiang,Liu Qingping...&Lin Changsong.(2018).Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway..International immunopharmacology,55,
MLA:
Pan Dongmei,et al."Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway.".International immunopharmacology 55.(2018):174-182